Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NSTG
- Price
- -
- Stock movement up
- +0.02 (11.29%)
- Company name
- NanoString Technologies Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 8.30M
- Ent value
- 239.78M
- Price/Sales
- 0.05
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 13.37%
- 1 year return
- -98.18%
- 3 year return
- -86.53%
- 5 year return
- -62.64%
- 10 year return
- -37.28%
Last updated: 2024-12-17
DIVIDENDS
NSTG does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.05 |
| Price to Book | - |
| EV to Sales | 1.48 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 48.12M |
| EPS (TTM) | -3.49 |
| FCF per share (TTM) | -2.80 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 162.47M |
| Gross profit (TTM) | 58.04M |
| Operating income (TTM) | -162.59M |
| Net income (TTM) | -166.43M |
| EPS (TTM) | -3.49 |
| EPS (1y forward) | -1.66 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 35.72% |
| Operating margin (TTM) | -100.07% |
| Profit margin (TTM) | -102.44% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 93.80M |
| Net receivables | 48.35M |
| Total current assets | 211.81M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 59.41M |
| Total assets | 274.71M |
| Accounts payable | 33.34M |
| Short/Current long term debt | 247.70M |
| Total current liabilities | 77.53M |
| Total liabilities | 325.28M |
| Shareholder's equity | -50.57M |
| Net tangible assets | -50.57M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -114.98M |
| Capital expenditures (TTM) | 20.76M |
| Free cash flow (TTM) | -133.49M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -60.58% |
| Return on Invested Capital | -91.06% |
| Cash Return on Invested Capital | -73.03% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| NSTG | S&P500 | |
| Current price drop from All-time high | -99.79% | -0.31% |
| Highest price drop | -99.95% | -56.47% |
| Date of highest drop | 21 Feb 2024 | 9 Mar 2009 |
| Avg drop from high | -39.43% | -11.07% |
| Avg time to new high | 29 days | 12 days |
| Max time to new high | 765 days | 1805 days |
COMPANY DETAILS
Marketcap
8.30M
Marketcap category
Small-cap
Description
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bank
Employees
550
Website
Investor relations
SEC filings
CEO
Robert Bradley Gray
Country
USA
City
Seattle
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner